News
Maharashtra recorded four new Covid-related fatalities, bringing the state's death toll to 25 since May. According to state ...
Hosted on MSN9mon
Intranasal COVID-19 Vaccine Gives Broad, Lasting Immunity Without A Needle In SightThat one is a viral vector vaccine – the gene that codes for the SARS-CoV-2 spike protein is carried inside a “shell” created from an adenovirus particle, which itself cannot replicate or ...
The largest COVID vaccine study to date has identified some risks associated with the shot. Researchers from the Global Vaccine Data Network (GVDN) in New Zealand analyzed 99 million people who ...
Viral-vectored vaccines can be designed quickly. One concern is that people can develop immunity to the viral vector, making this approach potentially less useful if booster shots need to be given.
Hosted on MSN9mon
New vector vaccine against COVID-19 provides long-term protectionCrucially, this vector poses no threat to humans, enhancing the vaccine's safety profile. In 2022, researchers from the department Viral Immunology headed by Prof. Luka Cicin-Sain at the Helmholtz ...
A new study has shown promising results for a nasal COVID-19 vaccine. Getty Images/iStockphoto Johnson & Johnson’s Janssen is a viral vector vaccine, which delivers DNA “instructions” to the ...
It’s a more traditional vaccine — something called a viral vector vaccine. A viral vector vaccine uses a modified version of a different virus — in this case, Adenovirus 26. This is a virus ...
Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models. Nature Communications , 2025; 16 (1) DOI: 10.1038/s41467-025-58504-z ...
Thanks to a clever modification of the baculovirus, vaccines can now be produced in insect cells more easily and cleaner.
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results